Triglyceride Concentration and Ischemic Heart Disease: An Eight-Year Follow-up in the Copenhagen Male Study
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Background —The role of triglycerides as a risk factor of ischemic heart disease (IHD) remains controversial. For the present study, we examined the relation between fasting triglycerides and risk of IHD in the Copenhagen Male Study. Methods and Results —Baseline measurements of fasting lipids and other IHD risk factors were obtained for 2906 white men (age range, 53 to 74 years) who were initially free of overt cardiovascular disease. During an 8-year follow-up period, 229 men had a first IHD event. Crude cumulative incidence rates of IHD were 4.6% for the lowest, 7.7% for the middle, and 11.5% for the highest third of triglyceride levels ( P for trend <.001). Compared with the lowest third level and adjusted for age, body mass index, alcohol, smoking, physical activity, hypertension, non–insulin-dependent diabetes mellitus, social class, and LDL and HDL cholesterol, relative risks of IHD (95% confidence interval) were 1.5 (1.0 to 2.3; P =.05) and 2.2 (1.4 to 3.4; P <.001) for the middle and highest third of triglyceride levels, respectively. When triglyceride levels were stratified by HDL cholesterol levels (triglyceride third multiplied by HDL cholesterol third), a clear gradient of risk of IHD was found with increasing triglyceride levels within each level of HDL cholesterol, including high HDL cholesterol level, which are thought to provide protection against IHD. Conclusions —In middle-aged and elderly white men, a high level of fasting triglycerides is a strong risk factor of IHD independent of other major risk factors, including HDL cholesterol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions
BURSTEIN, M., SCHOLNICK, H. R., & MORFIN, R. (1970) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42943-8 · Cited by 2,491
Cholesterol determination in high-density lipoproteins separated by three different methods.
Lopes-Virella, M. F., Stone, P., Ellis, S., & Colwell, J. A. (1977) · Clinical Chemistry · doi:10.1093/clinchem/23.5.882 · Cited by 1,841
Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
Austin, M. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410130125037 · Cited by 1,780
Hokanson, J. E., & Austin, M. A. (1996) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199604000-00014 · Cited by 1,706
Hyperinsulinemia as an independent risk factor for ischemic heart disease
Després, J.-P., Lamarche, B., Mauriège, P., Cantin, B., Dagenais, G. R., Moorjani, S., & Lupien, P.-J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341504 · Cited by 1,699
Hamsten, A., Wiman, B., de Faire, U., & Blombäck, M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198512193132501 · Cited by 1,342
Manninen, V, Tenkanen, L., Koskinen, P., Huttunen, J. K., Mänttäri, M., Heinonen, O. P., & Frick, M. H. (1992) · Circulation · doi:10.1161/01.cir.85.1.37 · Cited by 1,329
Cited by
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871
Gibbons, R. J., Abrams, J., Chatterjee, K., Daley, J., Deedwania, P. C., Douglas, J. S., Ferguson, T. B., Fihn, S. D., Fraker, T. D., Gardin, J. M., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02848-6 · Cited by 1,689
Carr, A., Samaras, K., Thorisdottir, A., Kaufmann, G. R., Chisholm, D. J., & Cooper, D. A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)08468-2 · Cited by 1,495
Dobiás̆ová, M., & Frohlich, J. (2001) · Clinical Biochemistry · doi:10.1016/s0009-9120(01)00263-6 · Cited by 1,438
Sarwar, N., Danesh, J., Eiriksdottir, G., Sigurdsson, G., Wareham, N., Bingham, S., Boekholdt, S. M., Khaw, K.-T., & Gudnason, V. (2007) · Circulation · doi:10.1161/circulationaha.106.637793 · Cited by 1,408
Wood, D., De Backer, G., Faergeman, O., Graham, I., Mancia, G., & Pyörälä, K. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)90209-x · Cited by 1,255
Jellinger, P. S., Handelsman, Y., Rosenblit, P. D., Bloomgarden, Z. T., Fonseca, V. A., Garber, A. J., Grunberger, G., Guerin, C. K., Bell, D. S. H., Mechanick, J. I., et al. (2017) · Endocrine Practice · doi:10.4158/ep171764.appgl · Cited by 1,094
Kahn, H. S. (2005) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-5-26 · Cited by 968
Physical Health Monitoring of Patients With Schizophrenia
Marder, S. R., Essock, S. M., Miller, A. L., Buchanan, R. W., Casey, D. E., Davis, J. M., Kane, J. M., Lieberman, J. A., Schooler, N. R., Covell, N., et al. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.8.1334 · Cited by 812
Jacobson, T. A., Ito, M. K., Maki, K. C., Orringer, C. E., Bays, H. E., Jones, P. H., McKenney, J. M., Grundy, S. M., Gill, E. A., Wild, R. A., et al. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.02.003 · Cited by 773
Gibbons, R. J., Chatterjee, K., Daley, J., Douglas, J. S., Fihn, S. D., Gardin, J. M., Grunwald, M. A., Levy, D., Lytle, B. W., O’Rourke, R. A., et al. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00150-3 · Cited by 633
Sandesara, P. B., Virani, S. S., Fazio, S., & Shapiro, M. D. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00184 · Cited by 608
Havel, P. J. (2005) · Nutrition Reviews · doi:10.1111/j.1753-4887.2005.tb00132.x · Cited by 607
Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives
Harris, W. S., Miller, M., Tighe, A. P., Davidson, M. H., & Schaefer, E. J. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.11.008 · Cited by 552
“[4] Jeppesen J, Hein H, Suadicani P, Gyntelberg F.”
BackgroundInfluentialJellinger, P. S., Smith, D. A., Mehta, A. E., Ganda, O., Handelsman, Y., Rodbard, H. W., Shepherd, M. D., & Seibel, J. A. (2012) · Endocrine Practice · doi:10.4158/ep.18.s1.1 · Cited by 533
Saturated Fat Consumption and Risk of Coronary Heart Disease and Ischemic Stroke: A Science Update
Nettleton, J. A., Brouwer, I. A., Geleijnse, J. M., & Hornstra, G. (2017) · Annals of Nutrition and Metabolism · doi:10.1159/000455681 · Cited by 510
Schwarz, J.-M., Linfoot, P., Dare, D., & Aghajanian, K. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.1.43 · Cited by 496
Sacks, F. M., Alaupovic, P., Moye, L. A., Cole, T. G., Sussex, B., Stampfer, M. J., Pfeffer, M. A., & Braunwald, E. (2000) · Circulation · doi:10.1161/01.cir.102.16.1886 · Cited by 490
Dyslipidemia and inflammation: an evolutionary conserved mechanism
Esteve, E., Ricart, W., & Fernández-Real, J. M. (2005) · Clinical Nutrition · doi:10.1016/j.clnu.2004.08.004 · Cited by 492
Evidence that triglycerides are an independent coronary heart disease risk factor
Cullen, P. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01127-9 · Cited by 462
The effects of antipsychotic therapy on serum lipids: a comprehensive review
Meyer, J. M., & Koro, C. E. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.01.014 · Cited by 407
Walldius, G., & Jungner, I. (2004) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01276.x · Cited by 396
Association rule mining to detect factors which contribute to heart disease in males and females
Nahar, J., Imam, T., Tickle, K. S., & Chen, Y.-P. P. (2013) · Expert Systems with Applications · doi:10.1016/j.eswa.2012.08.028 · Cited by 394
Hypertriglyceridaemia and risk of coronary artery disease
Reiner, Ž. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.31 · Cited by 387
High Ratio of Triglycerides to HDL-Cholesterol Predicts Extensive Coronary Disease
Luz, P. L. D., Favarato, D., Junior, J. R. F.-N., Lemos, P., & Chagas, A. C. P. (2008) · Clinics · doi:10.1590/s1807-59322008000400003 · Cited by 385
Postprandial hypertriglyceridemia impairs endothelial function by enhanced oxidant stress
Bae, J.-H., Bassenge, E., Kim, K.-B., Kim, Y.-N., Kim, K.-S., Lee, H.-J., Moon, K.-C., Lee, M.-S., Park, K.-Y., & Schwemmer, M. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00601-8 · Cited by 373
Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region.
Asia Pacific Cohort Studies Collaboration (2004) · Circulation · doi:10.1161/01.cir.0000145615.33955.83 · Cited by 358
Grundy, S. M. (2013) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2013.10.001 · Cited by 347
Grundy, S. M., Arai, H., Barter, P., Bersot, T. P., Betteridge, D. J., Carmena, R., Cuevas, A., Davidson, M. H., Genest, J., Kesäniemi, Y. A., et al. (2014) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2013.12.005 · Cited by 327
Serum Triglycerides and Risk of Coronary Heart Disease among Japanese Men and Women
Iso, H., Naito, Y., Sato, S., Kitamura, A., Okamura, T., Sankai, T., Shimamoto, T., Iida, M., & Komachi, Y. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.5.490 · Cited by 325
Effects of dietary fructose on plasma lipids in healthy subjects
Bantle, J. P., Raatz, S. K., Thomas, W., & Georgopoulos, A. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.5.1128 · Cited by 315
Testosterone and insulin resistance in the metabolic syndrome and T2DM in men
Rao, P. M., Kelly, D. M., & Jones, T. H. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.122 · Cited by 292
Meyer, J. M., Davis, V. G., Goff, D. C., McEvoy, J. P., Nasrallah, H. A., Davis, S. M., Rosenheck, R. A., Daumit, G. L., Hsiao, J., Swartz, M. S., et al. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.12.487 · Cited by 286
Skulas-Ray, A. C., Kris-Etherton, P. M., Harris, W. S., Vanden Heuvel, J. P., Wagner, P. R., & West, S. G. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.003871 · Cited by 280
McNamara, J. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00484-6 · Cited by 278
De Backer, G., Ambrosioni, E., Broch-Johnsen, K., Brotons, C., Cifkova, R., Dallongeville, J., Ebrahim, S., Faergeman, O., Graham, I., Mancia, G., et al. (2003) · European Journal of Cardiovascular Prevention and Rehabilitation · doi:10.1097/00149831-200312001-00001 · Cited by 274
Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy
Syrjänen, J., Mustonen, J., & Pasternack, A. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/15.1.34 · Cited by 257
New Perspectives on Atherogenesis: Role of Abnormal Triglyceride-Rich Lipoprotein Metabolism
Ginsberg, H. N. (2002) · Circulation · doi:10.1161/01.cir.0000035280.64322.31 · Cited by 255
Austin, M. A., McKnight, B., Edwards, K. L., Bradley, C. M., McNeely, M. J., Psaty, B. M., Brunzell, J. D., & Motulsky, A. G. (2000) · Circulation · doi:10.1161/01.cir.101.24.2777 · Cited by 255
Risk factors and cardiovascular disease in Turkey
Onat, A. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00500-7 · Cited by 252
McMahon, F. G., Fujioka, K., Singh, B. N., Mendel, C. M., Rowe, E., Rolston, K., Johnson, F., & Mooradian, A. D. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.14.2185 · Cited by 247
“Obesity increases the risk for cardiovascular disease (CVD), acting partly via hypertension, dyslipidemia, and type 2 diabetes mellitus, which occur commonly in obese subjects.5-13 Cardiovascular disease risk is also increased by obesity independently of other risk factors.8,14 Because of the medical benefits associat…”
BackgroundInfluentialTriglyceride as a risk factor for coronary artery disease
Gotto, A. M. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00770-x · Cited by 234
Twickler, T. B., Dallinga-Thie, G. M., Cohn, J. S., & Chapman, M. J. (2004) · Circulation · doi:10.1161/01.cir.0000125278.58527.f3 · Cited by 201
Prieur, X., Coste, H., & Rodríguez, J. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301302200 · Cited by 194
Role of Spirulina in the Control of Glycemia and Lipidemia in Type 2 Diabetes Mellitus
Parikh, P., Mani, U., & Iyer, U. (2001) · Journal of Medicinal Food · doi:10.1089/10966200152744463 · Cited by 193
Wood, D., De Backer, G., Faergeman, O., Graham, I., Mancia, G., & Pyörälä, K. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816100-00003 · Cited by 182
Hanak, V., Munoz, J., Teague, J., Stanley, A., & Bittner, V. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.03.069 · Cited by 167
Tanne, D., Koren-Morag, N., Graff, E., & Goldbourt, U. (2001) · Circulation · doi:10.1161/hc4901.100384 · Cited by 158
Faergeman, O., Holme, I., Fayyad, R., Bhatia, S., Grundy, S. M., Kastelein, J. J. P., LaRosa, J. C., Larsen, M. L., Lindahl, C., Olsson, A. G., et al. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.04.008 · Cited by 154
Willems van Dijk, K., Rensen, P. C., Voshol, P. J., & Havekes, L. M. (2004) · Current Opinion in Lipidology · doi:10.1097/00041433-200406000-00002 · Cited by 154
Changes in triglyceride levels and risk for coronary heart disease in young men.
Tirosh, A., Rudich, A., Shochat, T., Tekes-Manova, D., Israeli, E., Henkin, Y., Kochba, I., & Shai, I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-6-200709180-00007 · Cited by 151
“In the Copenhagen Male Study (5), middle-aged (age 54 years) white men with fasting triglyceride levels of 1.”
BackgroundInfluentialLeslie, M. A., Cohen, D. J. A., Liddle, D. M., Robinson, L. E., & Ma, D. W. L. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0049-7 · Cited by 143
“indicates that an 88 mg/dL increase in fasting TG levels elevates the risk of developing CVD by 14 % and 37 %, in males and females, respectively [3–8].”
BackgroundAustin, M. A., Rodriguez, B. L., McKnight, B., McNeely, M. J., Edwards, K. L., Curb, J. D., & Sharp, D. S. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)00956-5 · Cited by 129
Halcox, J. P., Banegas, J. R., Roy, C., Dallongeville, J., De Backer, G., Guallar, E., Perk, J., Hajage, D., Henriksson, K. M., & Borghi, C. (2017) · BMC Cardiovascular Disorders · doi:10.1186/s12872-017-0591-5 · Cited by 122
Ridker, P. M. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.097907 · Cited by 114
Iso, H., Imano, H., Yamagishi, K., Ohira, T., Cui, R., Noda, H., Sato, S., Kiyama, M., Okada, T., Hitsumoto, S., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.08.028 · Cited by 104
Metabolic abnormalities: triglyceride and low-density lipoprotein
Krauss, R. M., & Siri, P. W. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.03.016 · Cited by 102
Miller, M., Ginsberg, H. N., & Schaefer, E. J. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.11.046 · Cited by 102
Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia
Skulas-Ray, A. C., West, S. G., Davidson, M. H., & Kris-Etherton, P. M. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.7.1237 · Cited by 91
“The Copenhagen Male Study found that men in the highest tertile of fasting triglycerides (> 142 mg/dl, average 218 mg/dl) experienced more than twice the risk for ischemic heart disease vs those in the lowest tertile (< 97 mg/dl, average 78 mg/dl) [7].”
BackgroundGarg, A., & Simha, V. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0275 · Cited by 89
Aude, Y. W., Agatston, A. S., Lopez-Jimenez, F., Lieberman, E. H., Almon, M., Hansen, M., Rojas, G., Lamas, G. A., & Hennekens, C. H. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.19.2141 · Cited by 76
Musa-Veloso, K., Binns, M. A., Kocenas, A. C., Poon, T., Elliot, J. A., Rice, H., Oppedal-Olsen, H., Lloyd, H., & Lemke, S. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00272.x · Cited by 73
Corsetti, J. P., Bakker, S. J. L., Sparks, C. E., & Dullaart, R. P. F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039110 · Cited by 66
Satoh, H., Nishino, T., Tomita, K., & Tsutsui, H. (2006) · Circulation Journal · doi:10.1253/circj.70.227 · Cited by 60
Mazza, A., Tikhonoff, V., Schiavon, L., & Casiglia, E. (2005) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2005.00940.x · Cited by 53
Orth, M., Weng, W., Funke, H., Steinmetz, A., Assmann, G., Nauck, M., Dierkes, J., Ambrosch, A., Weisgraber, K. H., Mahley, R. W., et al. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.5.1306 · Cited by 42
Stroes, E. S. G., Susekov, A. V., de Bruin, T. W. A., Kvarnström, M., Yang, H., & Davidson, M. H. (2018) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2017.10.012 · Cited by 38
Okamura, T., Kokubo, Y., Watanabe, M., Higashiyama, A., Ono, Y., Miyamoto, Y., Yoshimasa, Y., & Okayama, A. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.09.012 · Cited by 35
Jerrell, J., McIntyre, R., & Tripathi, A. (2010) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.4.3.2 · Cited by 31
Corsetti, J. P., Gansevoort, R. T., Bakker, S. J. L., Navis, G., Sparks, C. E., & Dullaart, R. P. F. (2012) · Metabolism · doi:10.1016/j.metabol.2011.11.010 · Cited by 30
Ren, Y., Ren, Q., Lu, J., Guo, X., Huo, X., Ji, L., & Yang, X. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2960 · Cited by 18
Hypertriglyceridemia: molecular and genetic landscapes
Scicchitano, P., Amati, F., Ciccone, M. M., D’Ascenzi, F., Imbalzano, E., Liga, R., Paolillo, S., Pastore, M. C., Rinaldi, A., Mattioli, A. V., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126364 · Cited by 13
Metadata
- Authors
- Jeppesen, J. Ø., Hein, H. O., Suadicani, P., & Gyntelberg, F.
- Venue
- Circulation
- Published
- 1998-03-24
- Volume
- 97
- Issue
- 11
- Pages
- 1029-1036
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2077247955
- Cited by
- 676
- References
- 43
- FWCI
- 61.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.